Case Report

The coexistence of hemophagocytic syndrome and DRESS syndrome that develops in the course of sepsis in an elderly patient in intensive care unit

April 19, 2021
  • Salih Tünbekici *
  • Şükriye Miray Kılınçer Bozgül
  • Devrim Bozkurt
EN TR

The coexistence of hemophagocytic syndrome and DRESS syndrome that develops in the course of sepsis in an elderly patient in intensive care unit

Abstract

Sepsis is one of the leading causes of mortality in intensive care units. Its mortality increases, especially with the high number of comorbidities and immunosuppression. Hemophagocytic syndrome is an uncontrolled cytokine storm that develops in the course of increased inflammatory conditions such as sepsis. The clinical picture is very wide; because of nonspecific symptoms. For this reason; to diagnose hemophagocytic syndrome, it must be kept in mind. Mortality in hemophagocytic syndrome is especially high in intensive care patients. Drug reaction with eosinophilia and systemic symptoms syndrome is a rare, infrequent drug reaction. The clinical picture is heterogeneous and symptoms may be prolonged despite discontinuation of the drug. Overlap of different diagnoses in elderly patients; In the presence of multiple drug use and chronic diseases, clinical management is difficult and early initiation of effective treatment can be delayed. In this case report; a 66-year-old male patient who underwent nephrostomy due to bilateral hydronephrosis and who developed sepsis and HPS in the follow-up after hospitalization with high fever and complicated with drug reaction with eosinophilia and systemic symptoms syndrome during treatment is presented.

Keywords

References

  1. Shankar-Hari M, Phillips GS, Levy ML, et al. Developing a New Definition and Assessing New Clinical Criteria for Septic Shock: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). Jama 2016; 315 (8): 775-87.
  2. Kim HI, Park S. Sepsis: Early Recognition and Optimized Treatment. Tuberc Respir Dis (Seoul) 2019; 82 (1): 6-14.
  3. Lachmann G, La Rosée P, Schenk T, Brunkhorst FM, Spies C. Hemophagocytic lymphohistiocytosis: A diagnostic challenge on the ICU. Anaesthesist 2016; 65 (10): 776-86.
  4. Walsh SA, Creamer D. Drug reaction with eosinophilia and systemic symptoms (DRESS): a clinical update and review of current thinking. Clin Exp Dermatol 2011; 36 (1): 6-11.
  5. Bozkurt D. İç Hastalıklarında İmmün Sistem İlişkili Aciller. 1 Baskı. Ankara: Palme Yayınevi; 2020: 69-80.
  6. Henter JI, Horne A, Aricó M, et al. HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 2007; 48 (2): 124-31.
  7. Kardaun SH, Sekula P, Valeyrie-Allanore L, et al. Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study. Br J Dermatol 2013; 169 (5): 1071-80.

Details

Primary Language

English

Subjects

Health Care Administration

Journal Section

Case Report

Authors

Salih Tünbekici *
0000-0001-8804-7636
Türkiye

Şükriye Miray Kılınçer Bozgül
0000-0002-3995-5096
Türkiye

Devrim Bozkurt
0000-0003-4557-3390
Türkiye

Publication Date

April 19, 2021

Submission Date

January 18, 2021

Acceptance Date

March 18, 2021

Published in Issue

Year 1970

Vancouver
1.Salih Tünbekici, Şükriye Miray Kılınçer Bozgül, Devrim Bozkurt. The coexistence of hemophagocytic syndrome and DRESS syndrome that develops in the course of sepsis in an elderly patient in intensive care unit. EJM. 2021 Apr. 1;74-7. doi:10.19161/etd.915702

Ege Journal of Medicine enables the sharing of articles according to the Attribution-Non-Commercial-Share Alike 4.0 International (CC BY-NC-SA 4.0) license.